Pressure Ulcers Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pressure ulcers are an injury that breaks down the skin and underlying tissue. The parts of the body most at risk of developing pressure ulcers are those that are not covered by a large amount of body fat and are in direct contact with a supporting surface (bed or a wheelchair). Causes include continuous pressure, friction, and shear. Treatment includes antibiotics and nutrition.
The Pressure Ulcers Drugs in Development market research report provides an overview of the Pressure Ulcers pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pressure Ulcers, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pressure Ulcers and features dormant and discontinued projects.
Pressure Ulcers Pipeline Drugs Market Targets
The targets of the pressure ulcers pipeline drugs market are Beta Nerve Growth Factor, Phosphodiesterase 5, and Soluble Guanylate Cyclase.
Pressure Ulcers pipeline drugs market, by targets
For more target insights, download a free report sample
Mechanisms of Action of Pressure Ulcers Pipeline Drugs Market
The mechanisms of action of the pressure ulcers pipeline drugs market Beta Nerve Growth Factor Activator, Phosphodiesterase 5 Inhibitor, and Soluble Guanylate Cyclase Activator.
Pressure Ulcers pipeline drugs market, by mechanisms of action
For more mechanisms of action insights, download a free report sample
Routes of Administration in Pressure Ulcers Pipeline Drugs Market
The routes of administration in the pressure ulcers pipeline drugs market are topical, cutaneous, and ophthalmic.
Pressure Ulcers pipeline drugs market, by routes of administration
For more routes of administration insights, download a free report sample
Molecule Types in Pressure Ulcers Pipeline Drugs Market
The molecule types in the pressure ulcers pipeline drugs market are small molecule, recombinant peptide, and synthetic peptide.
Pressure Ulcers pipeline drugs market, by molecule types
For more molecule type insights, download a free report sample
Key Pressure Ulcers Pipeline Drugs Market Companies
Some of the key companies in the pressure ulcers pipeline drugs market are EyeGene Inc, MimeTech Srl, NovaLead Pharma Pvt Ltd, Shionogi & Co Ltd, and Topadur Pharma AG.
Pressure Ulcers pipeline drugs market, by key companies
To know more about key companies, download a free report sample
Market report overview
Targets | Beta Nerve Growth Factor, Phosphodiesterase 5, and Soluble Guanylate Cyclase |
Mechanisms of Action | Beta Nerve Growth Factor Activator, Phosphodiesterase 5 Inhibitor, and Soluble Guanylate Cyclase Activator |
Routes of Administration | Topical, Cutaneous, and Ophthalmic |
Molecule Types | Small Molecule, Recombinant Peptide, and Synthetic Peptide |
Key Companies | EyeGene Inc, MimeTech Srl, NovaLead Pharma Pvt Ltd, Shionogi & Co Ltd, and Topadur Pharma AG |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Pressure Ulcers (Dermatology).
- Reviews of pipeline therapeutics for Pressure Ulcers (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key companies involved in Pressure Ulcers (Dermatology) therapeutics and enlists all their major and minor projects.
- Evaluation of Pressure Ulcers (Dermatology) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Pressure Ulcers (Dermatology).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Pressure Ulcers (Dermatology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Pressure Ulcers (Dermatology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
MimeTech Srl
NovaLead Pharma Pvt Ltd
Shionogi & Co Ltd
Topadur Pharma AG
Table of Contents
Table
Figures
Frequently asked questions
-
What are the targets of the Pressure Ulcers pipeline drugs market?
The targets of the pressure ulcers pipeline drugs market are Beta Nerve Growth Factor, Phosphodiesterase 5, and Soluble Guanylate Cyclase.
-
What are the mechanisms of action of the Pressure Ulcers pipeline drugs market?
The mechanisms of action of the pressure ulcers pipeline drugs market are Beta Nerve Growth Factor Activator, Phosphodiesterase 5 Inhibitor, and Soluble Guanylate Cyclase Activator.
-
What are the routes of administration in the Pressure Ulcers pipeline drugs market?
The routes of administration in the pressure ulcers pipeline drugs market are topical, cutaneous, and ophthalmic.
-
What are the molecule types in the Pressure Ulcers pipeline drugs market?
The molecule types in the pressure ulcers pipeline drugs market are small molecule, recombinant peptide, and synthetic peptide.
-
Which are the key companies in the Pressure Ulcers pipeline drugs market?
Some of the key companies in the pressure ulcers pipeline drugs market are EyeGene Inc, MimeTech Srl, NovaLead Pharma Pvt Ltd, Shionogi & Co Ltd, and Topadur Pharma AG.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.